drugset / Trial / NCT06336993

Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP

NCT06336993

Phase 4 Completed 71 enrolled Zhejiang Provincial Tongde Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this randomized controlled trial was to explore the clinical efficacy and safety of HXTL in the treatment of NSLBP based on TCM principles and to compare the clinical outcomes of different syndromes of NSLBP with celecoxib.In this study, 80 patients with NSLBP were recruited and randomly grouped to use TCM compound and celeoxib respectively for intervention. The pain status and lumbar function use scale of patients were scored before intervention, 1 week, 2 weeks and 3 weeks after intervention, and the adverse reactions of patients after medication were recorded, and the clinical efficacy of the two groups of patients was compared finally.

Timeline

Start
2022-01-01
Primary completion
2023-06-16
Completion
2023-12-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg
Subject herbal compound Traditional medicine (herbal / TCM) 200 ml
Subject herbal compound Traditional medicine (herbal / TCM) 300 ml

Indications

No indication recorded.